Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

by Maëlle Duffey, Cecilia P. Sanchez, Michael Lanzer
Published 2018-03-01

Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species

by Donelly A. van Schalkwyk, Robert W. Moon, Maëlle Duffey, Didier Leroy, Colin J. Sutherland
Published 2021-12-01

SC83288 is a clinical development candidate for the treatment of severe malaria

by Stefano Pegoraro, Maëlle Duffey, Thomas D Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K Fehler, Leonardo Lucantoni, Vicky M Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J Vial, Stefan Strobl, Cecilia P Sanchez, Michael Lanzer
Published 2017-01-01

Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

by Stefano Pegoraro, Maëlle Duffey, Thomas D. Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K. Fehler, Leonardo Lucantoni, Vicky M. Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J. Vial, Stefan Strobl, Cecilia P. Sanchez, Michael Lanzer
Published 2017-04-01